Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 7 | 2023 | 768 | 0.880 |
Why?
|
Intestinal Obstruction | 2 | 2018 | 89 | 0.500 |
Why?
|
Teratoma | 3 | 2022 | 52 | 0.420 |
Why?
|
Dermoid Cyst | 2 | 2022 | 15 | 0.400 |
Why?
|
Child | 11 | 2023 | 7216 | 0.320 |
Why?
|
Ovariectomy | 3 | 2023 | 82 | 0.320 |
Why?
|
Unnecessary Procedures | 1 | 2023 | 52 | 0.220 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 48 | 0.200 |
Why?
|
Ovarian Cysts | 1 | 2021 | 17 | 0.190 |
Why?
|
Cystadenoma | 1 | 2021 | 19 | 0.190 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 8 | 0.170 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2019 | 70 | 0.170 |
Why?
|
Tracheoesophageal Fistula | 1 | 2019 | 12 | 0.170 |
Why?
|
alpha-Fetoproteins | 1 | 2019 | 44 | 0.170 |
Why?
|
Diatrizoate Meglumine | 1 | 2018 | 19 | 0.160 |
Why?
|
Tissue Adhesions | 1 | 2018 | 50 | 0.160 |
Why?
|
Retrospective Studies | 9 | 2023 | 9127 | 0.150 |
Why?
|
Biomarkers, Tumor | 3 | 2023 | 1541 | 0.150 |
Why?
|
Adolescent | 8 | 2023 | 9305 | 0.150 |
Why?
|
Pandemics | 1 | 2022 | 777 | 0.130 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 1727 | 0.130 |
Why?
|
Tonsillitis | 1 | 2015 | 5 | 0.130 |
Why?
|
Child, Preschool | 5 | 2022 | 3756 | 0.130 |
Why?
|
Epigenetic Repression | 1 | 2015 | 1 | 0.130 |
Why?
|
Streptococcus pyogenes | 1 | 2015 | 35 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2015 | 56 | 0.120 |
Why?
|
Young Adult | 6 | 2023 | 6368 | 0.120 |
Why?
|
Laparoscopy | 1 | 2022 | 777 | 0.120 |
Why?
|
Adenocarcinoma | 2 | 2015 | 1185 | 0.120 |
Why?
|
Humans | 16 | 2023 | 89613 | 0.110 |
Why?
|
Contrast Media | 1 | 2018 | 1084 | 0.110 |
Why?
|
Autoimmune Lymphoproliferative Syndrome | 1 | 2013 | 2 | 0.110 |
Why?
|
Carcinogenesis | 1 | 2015 | 213 | 0.110 |
Why?
|
Polyomavirus | 1 | 2012 | 16 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 250 | 0.100 |
Why?
|
Pancreatitis | 1 | 2013 | 86 | 0.100 |
Why?
|
Genome, Viral | 1 | 2012 | 82 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 333 | 0.100 |
Why?
|
Female | 12 | 2023 | 46401 | 0.100 |
Why?
|
Autoimmunity | 1 | 2013 | 169 | 0.100 |
Why?
|
Cytokines | 1 | 2015 | 806 | 0.090 |
Why?
|
Smoking | 1 | 2015 | 625 | 0.090 |
Why?
|
MicroRNAs | 1 | 2015 | 555 | 0.090 |
Why?
|
Colectomy | 1 | 2008 | 173 | 0.070 |
Why?
|
Lymph Node Excision | 1 | 2008 | 219 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 682 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 476 | 0.070 |
Why?
|
Risk Factors | 2 | 2021 | 5517 | 0.070 |
Why?
|
Hospitalization | 2 | 2023 | 880 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 571 | 0.060 |
Why?
|
Infant | 2 | 2022 | 3176 | 0.050 |
Why?
|
Adult | 4 | 2022 | 26704 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 1605 | 0.050 |
Why?
|
Prognosis | 1 | 2011 | 3785 | 0.050 |
Why?
|
Frozen Sections | 1 | 2022 | 50 | 0.050 |
Why?
|
Obesity | 1 | 2008 | 971 | 0.050 |
Why?
|
Laparotomy | 1 | 2022 | 68 | 0.050 |
Why?
|
Preoperative Care | 1 | 2023 | 395 | 0.050 |
Why?
|
Organ Sparing Treatments | 1 | 2021 | 46 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 2668 | 0.040 |
Why?
|
Inhibins | 1 | 2019 | 37 | 0.040 |
Why?
|
Esophageal Atresia | 1 | 2019 | 14 | 0.040 |
Why?
|
Ovary | 1 | 2021 | 262 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 2016 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2019 | 2763 | 0.040 |
Why?
|
Ultrasonography | 1 | 2021 | 714 | 0.040 |
Why?
|
Pancreas | 1 | 2019 | 249 | 0.040 |
Why?
|
Intestine, Small | 1 | 2018 | 299 | 0.030 |
Why?
|
Health Care Costs | 1 | 2018 | 236 | 0.030 |
Why?
|
Risk Assessment | 1 | 2023 | 2304 | 0.030 |
Why?
|
Cohort Studies | 2 | 2015 | 2878 | 0.030 |
Why?
|
NFI Transcription Factors | 1 | 2015 | 7 | 0.030 |
Why?
|
Algorithms | 1 | 2023 | 1903 | 0.030 |
Why?
|
Smoke | 1 | 2015 | 27 | 0.030 |
Why?
|
Length of Stay | 1 | 2018 | 743 | 0.030 |
Why?
|
Kallikreins | 1 | 2015 | 47 | 0.030 |
Why?
|
Tonsillectomy | 1 | 2015 | 30 | 0.030 |
Why?
|
Prospective Studies | 1 | 2022 | 4309 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2019 | 2488 | 0.030 |
Why?
|
Down-Regulation | 1 | 2015 | 520 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 571 | 0.030 |
Why?
|
Lung | 1 | 2019 | 1273 | 0.030 |
Why?
|
DNA Restriction Enzymes | 1 | 2012 | 97 | 0.030 |
Why?
|
fas Receptor | 1 | 2013 | 77 | 0.030 |
Why?
|
Warts | 1 | 2012 | 11 | 0.030 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2015 | 162 | 0.030 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2012 | 47 | 0.030 |
Why?
|
Pilot Projects | 1 | 2015 | 870 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 725 | 0.030 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 217 | 0.020 |
Why?
|
Chromatin | 1 | 2015 | 402 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2013 | 160 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 171 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 3465 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2022 | 2297 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 529 | 0.020 |
Why?
|
Virus Replication | 1 | 2012 | 326 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 337 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2015 | 1862 | 0.020 |
Why?
|
DNA Methylation | 1 | 2015 | 663 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 1281 | 0.020 |
Why?
|
Biopsy | 1 | 2013 | 1183 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 868 | 0.020 |
Why?
|
Skin | 1 | 2012 | 589 | 0.020 |
Why?
|
Genetic Testing | 1 | 2013 | 539 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 2582 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2015 | 1668 | 0.020 |
Why?
|
Body Size | 1 | 2008 | 93 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 3024 | 0.020 |
Why?
|
Male | 3 | 2018 | 42488 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 774 | 0.020 |
Why?
|
Aged | 2 | 2013 | 19158 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2008 | 2003 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 4160 | 0.010 |
Why?
|
Middle Aged | 1 | 2008 | 26012 | 0.010 |
Why?
|